{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T12:01:12Z","timestamp":1794916872461,"version":"4.9.1"},"reference-count":32,"publisher":"The Journal of Rheumatology","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2019,4]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>Interstitial lung disease (ILD) is commonly associated with rheumatoid arthritis (RA) and can have significant morbidity and mortality. The objective of this study was to calculate the prevalence, incidence, healthcare costs, and mortality of RA-related ILD (RA-ILD) in the United States.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>This retrospective cohort analysis used the Truven Health MarketScan Commercial and Medicare Supplemental health insurance databases from 2003 to 2014 and the Social Security Administration death database. Patients with RA-ILD were selected based on diagnoses on medical claims. Outcomes were 1-year prevalence and incidence of RA-ILD among the general enrollee population, all-cause and respiratory-related healthcare costs (2014 US$), and all-cause survival for a subset of newly diagnosed patients with vital status information. This analysis was descriptive. No statistical testing was conducted.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>Prevalence of RA-ILD ranged from 3.2 to 6.0 cases per 100,000 people across the 10-year period and incidence ranged from 2.7 to 3.8 cases per 100,000 people. There were 750 incident patients with 5 years of followup data. Over that time, 72% had an inpatient admission and 76% had an emergency room visit. Mean total 5-year costs were US$173,405 per patient (SD $158,837). Annual per-patient costs were highest in years 1 and 5. At 5 years after first diagnosis in the data, 35.9% of patients had died.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>Prevalence of RA-ILD increased over time. For patients who could be followed over a 5-year period, healthcare use and costs were somewhat stable over time, but were substantial. RA-ILD is associated with decreased survival.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.171315","type":"journal-article","created":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T07:19:24Z","timestamp":1542266364000},"page":"360-369","source":"Crossref","is-referenced-by-count":216,"title":["Rheumatoid Arthritis\u2013Interstitial Lung Disease in the United States: Prevalence, Incidence, and Healthcare Costs and Mortality"],"prefix":"10.3899","volume":"46","author":[{"given":"Karina","family":"Raimundo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua J.","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy L.","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6210-4185","authenticated-orcid":false,"given":"Amanda M.","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley L.","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aryeh","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey J.","family":"Swigris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2018,11,15]]},"reference":[{"key":"2019040109152888000_46.4.360.1","doi-asserted-by":"publisher","DOI":"10.1183\/09059180.00008014"},{"key":"2019040109152888000_46.4.360.2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201004-0622OC"},{"key":"2019040109152888000_46.4.360.3","doi-asserted-by":"publisher","DOI":"10.1378\/chest.13-2408"},{"key":"2019040109152888000_46.4.360.4","doi-asserted-by":"publisher","DOI":"10.1185\/03007990903422307"},{"key":"2019040109152888000_46.4.360.5","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.156.2.9609016"},{"key":"2019040109152888000_46.4.360.6","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-010-1492-5"},{"key":"2019040109152888000_46.4.360.7","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.101133"},{"key":"2019040109152888000_46.4.360.8","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq135"},{"key":"2019040109152888000_46.4.360.9","doi-asserted-by":"publisher","DOI":"10.1186\/ar2482"},{"key":"2019040109152888000_46.4.360.10","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12890-015-0165-1","article-title":"Clinical and economic burden of idiopathic pulmonary fibrosis: a retrospective cohort study","volume":"16","author":"Raimundo","year":"2016","journal-title":"BMC Pulm Med"},{"key":"2019040109152888000_46.4.360.11","unstructured":"Centers for Disease Control and Prevention . National Center for Health Statistics. International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM). [Internet. Accessed October 12, 2018.] Available from: www.cdc.gov\/nchs\/icd\/icd9cm.htm"},{"key":"2019040109152888000_46.4.360.12","unstructured":"First Databank. [Internet. Accessed October 12, 2018.] Available from: www.fdbhealth.com"},{"key":"2019040109152888000_46.4.360.13","first-page":"845","article-title":"Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review","volume":"65","author":"Avouac","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2019040109152888000_46.4.360.14","doi-asserted-by":"publisher","DOI":"10.1002\/art.20018"},{"key":"2019040109152888000_46.4.360.15","doi-asserted-by":"publisher","DOI":"10.1111\/resp.12234"},{"key":"2019040109152888000_46.4.360.16","doi-asserted-by":"publisher","DOI":"10.1136\/ard.56.8.463"},{"key":"2019040109152888000_46.4.360.17","doi-asserted-by":"publisher","DOI":"10.3109\/03009749509099296"},{"key":"2019040109152888000_46.4.360.18","doi-asserted-by":"publisher","DOI":"10.1136\/ard.49.10.753"},{"key":"2019040109152888000_46.4.360.19","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/oxfordjournals.aje.a112878","article-title":"The epidemiology of rheumatoid arthritis in Rochester, Minnesota: a study of incidence, prevalence, and mortality","volume":"111","author":"Linos","year":"1980","journal-title":"Am J Epidemiol"},{"key":"2019040109152888000_46.4.360.20","doi-asserted-by":"publisher","DOI":"10.1002\/art.27405"},{"key":"2019040109152888000_46.4.360.21","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12890-016-0269-2","article-title":"Variable course of disease of rheumatoid arthritis-associated usual interstitial pneumonia compared to other subtypes","volume":"16","author":"Nurmi","year":"2016","journal-title":"BMC Pulm Med"},{"key":"2019040109152888000_46.4.360.22","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu165"},{"key":"2019040109152888000_46.4.360.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2013.05.001"},{"key":"2019040109152888000_46.4.360.24","doi-asserted-by":"crossref","first-page":"759760","DOI":"10.1155\/2013\/759760","article-title":"The multifaceted aspects of interstitial lung disease in rheumatoid arthritis","volume":"2013","author":"Cavagna","year":"2013","journal-title":"Biomed Res Int"},{"key":"2019040109152888000_46.4.360.25","doi-asserted-by":"publisher","DOI":"10.1177\/1479972310393758"},{"key":"2019040109152888000_46.4.360.26","first-page":"1","article-title":"United States life tables, 2012","volume":"65","author":"Arias","year":"2016","journal-title":"Natl Vital Stat Rep"},{"key":"2019040109152888000_46.4.360.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2013.05.002"},{"key":"2019040109152888000_46.4.360.28","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00357-2015"},{"key":"2019040109152888000_46.4.360.29","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211138"},{"key":"2019040109152888000_46.4.360.30","unstructured":"United States Census Bureau . U.S. and world population clock. [Internet. Accessed October 12, 2018.] Available from: www.census.gov\/popclock"},{"key":"2019040109152888000_46.4.360.31","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.annepidem.2015.03.008","article-title":"Enrollment factors and bias of disease prevalence estimates in administrative claims data","volume":"25","author":"Jensen","year":"2015","journal-title":"Ann Epidemiol"},{"key":"2019040109152888000_46.4.360.32","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.112.968826"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.171315","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T12:17:48Z","timestamp":1554121068000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.171315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,15]]},"references-count":32,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,4,1]]},"published-print":{"date-parts":[[2019,4]]}},"alternative-id":["10.3899\/jrheum.171315"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.171315","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,15]]}}}